BioXcel Therapeutics
BTAI
BTAI
108 hedge funds and large institutions have $512M invested in BioXcel Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 104 → 108 (+4)
0.81% more ownership
Funds ownership: 2.51% → 3.32% (+0.81%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
108
Holding in Top 10
1
Calls
$23.3M
Puts
$7.13M
Top Buyers
| 1 | +$76.3M | |
| 2 | +$25.5M | |
| 3 | +$18.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.9M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$13M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$11.8M | |
| 3 | -$11.4M | |
| 4 |
Renaissance Technologies
New York
|
-$8.25M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$7.95M |